Serialization and Traceability in the Middle East: Navigating a Complex Compliance Landscape
Over the past few years, the Middle East has taken significant strides in implementing traceability regulations, particularly in countries like the UAE,...
Sri Lanka Extends Barcode Grace Period for Medicines: What MAHs Need to Know
The National Medicines Regulatory Authority (NMRA) of Sri Lanka has issued a key update for Marketing Authorization Holders (MAHs) regarding the use of...
DSCSA Enforcement Timeline: What Trading Partners Need to Know in 2025
The Drug Supply Chain Security Act (DSCSA) continues its phased implementation throughout 2025, and the Healthcare Distribution Alliance (HDA) has...
Ethiopia’s Latest Pharma Serialization & Traceability Update: Key Deadlines for Exporters
The Ethiopian Food and Drug Authority (EFDA) has released a crucial update regarding its national pharmaceutical traceability initiative. This marks a...
Italy’s Pharmaceutical Traceability: Stabilization Period
Italy continues its structured transition towards full compliance with the EU Falsified Medicines Directive (FMD), and now, a critical update has been...
The First Step Towards Pharmaceutical Serialization in Oman
Pharmaceutical serialization has become a crucial global initiative to combat counterfeit drugs, improve patient safety, and enhance supply chain...
Mastering DSCSA Exception Management: Building Resilience in Serialized Supply Chains
Introduction As the U.S. Drug Supply Chain Security Act (DSCSA) enforcement milestones approach, manufacturers, distributors, and trading partners must...
Pharmaceutical Serialization in the GCC: Spotlight on Bahrain
Welcome to the third entry in our blog series on pharmaceutical serialization across the Middle East. In this edition, we turn our attention to the...